RESUMO
Huntington's disease (HD) is a neurodegenerative disorder caused by a glutamine expansion at the first exon of the huntingtin gene. Huntingtin protein (Htt) is ubiquitously expressed and it is localized in several organelles, including endosomes. HD is associated with a failure in energy metabolism and oxidative damage. Ascorbic acid is a powerful antioxidant highly concentrated in the brain where it acts as a messenger, modulating neuronal metabolism. It is transported into neurons via the sodium-dependent vitamin C transporter 2 (SVCT2). During synaptic activity, ascorbic acid is released from glial reservoirs to the extracellular space, inducing an increase in SVCT2 localization at the plasma membrane. Here, we studied SVCT2 trafficking and localization in HD. SVCT2 is decreased at synaptic terminals in YAC128 male mice. Using cellular models for HD (STHdhQ7 and STHdhQ111 cells), we determined that SVCT2 trafficking through secretory and endosomal pathways is altered in resting conditions. We observed Golgi fragmentation and SVCT2/Htt-associated protein-1 mis-colocalization. Additionally, we observed altered ascorbic acid-induced calcium signaling that explains the reduced SVCT2 translocation to the plasma membrane in the presence of extracellular ascorbic acid (active conditions) described in our previous results. Therefore, SVCT2 trafficking to the plasma membrane is altered in resting and active conditions in HD, explaining the redox imbalance observed during early stages of the disease.
Assuntos
Doença de Huntington/metabolismo , Transporte Proteico/fisiologia , Transportadores de Sódio Acoplados à Vitamina C/metabolismo , Sinaptossomos/metabolismo , Animais , Masculino , Camundongos , Camundongos Transgênicos , Neurônios/metabolismo , OxirreduçãoRESUMO
A key feature of neurotransmission is its ability to adapt to changes in neuronal environment, which is essential for many brain functions. Homeostatic synaptic plasticity (HSP) emerges as a compensatory mechanism used by neurons to adjust their excitability in response to changes in synaptic activity. Recently, glial cells emerged as modulators for neurotransmission by releasing gliotransmitters into the synaptic cleft through pathways that include P2X7 receptors (P2X7R), connexons, and pannexons. However, the role of gliotransmission in the activity-dependent adjustment of presynaptic strength is still an open question. Here, we investigated whether glial cells participate in HSP upon chronic inactivity and the role of adenosine triphosphate (ATP), connexin43 hemichannels (Cx43HCs), and pannexin1 (Panx1) channels in this process. We used immunocytochemistry against vesicular glutamate transporter 1 (vGlut1) to estimate changes in synaptic strength in hippocampal dissociated cultures. Pharmacological manipulations indicate that glial-derived ATP and P2X7R are required for HSP. In addition, inhibition of Cx43 and Panx1 channels reveals a pivotal role for these channels in the compensatory adjustment of synaptic strength, emerging as new pathways for ATP release upon inactivity. The involvement of Panx1 channels was confirmed by using Panx1-deficient animals. Lacking Panx1 in neurons is sufficient to prevent the P2X7R-dependent upregulation of presynaptic strength; however, the P2X7R-dependent compensatory adjustment of synapse density requires both neuronal and glial Panx1. Together, our data supports an essential role for glial ATP signaling and Cx43HCs and Panx1 channels in the homeostatic adjustment of synaptic strength in hippocampal cultures upon chronic inactivity.
Assuntos
Trifosfato de Adenosina/metabolismo , Conexinas/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Neuroglia/metabolismo , Neurônios/metabolismo , Sinapses/metabolismo , Transmissão Sináptica/fisiologia , Animais , Conexina 43/metabolismo , Conexinas/genética , Hipocampo/metabolismo , Camundongos , Camundongos Knockout , Proteínas do Tecido Nervoso/genética , Ratos , Receptores Purinérgicos P2X7/metabolismoRESUMO
Lysophosphatidic acid (LPA) is one of the main membrane-derived lysophospholipids, inducing diverse cellular responses like cell proliferation, cell death inhibition, and cytoskeletal rearrangement, and thus is important in many biological processes. In the central nervous system (CNS), post-mitotic neurons release LPA extracellularly whereas astrocytes do not. Astrocytes play a key role in brain development and pathology, producing various cytokines, chemokines, growth factors, and extracellular matrix (ECM) components that act as molecular coordinators of neuron-glia communication. However, many molecular mechanisms underlying these events remain unclear-in particular, how the multifaceted interplay between the signaling pathways regulated by lysophospholipids is integrated in the complex nature of the CNS. Previously we showed that LPA-primed astrocytes induce neuronal commitment by activating LPA1-LPA2 receptors. Further, we revealed that these events were mediated by modulation and organization of laminin levels by astrocytes, through the induction of the epidermal growth factor receptor (EGFR) signaling pathway and the activation of the mitogen-activated protein (MAP) kinase (MAPK) cascade in response to LPA (Spohr et al., 2008, 2011). In the present work, we aimed to answer whether LPA affects astrocytic production and rearrangement of fibronectin, and to investigate the mechanisms involved in neuronal differentiation and maturation of cortical neurons induced by LPA-primed astrocytes. We show that PKA activation is required for LPA-primed astrocytes to induce neurite outgrowth and neuronal maturation and to rearrange and enhance the production of fibronectin and laminin. We propose a potential mechanism by which neurons and astrocytes communicate, as well as how such interactions drive cellular events such as neurite outgrowth, cell fate commitment, and maturation.
RESUMO
As funções fisiológicas da proteína prion (PrPc) estão sob ampla investigação e caracterização, especialmente as funções associadas ao desenvolvimento cerebral. Destaca-se que a associação de PrPc com Stress Inducible Protein 1 (STI1), induz neuritogênese e neuroproteção via proteína cinase extracelular reguladora (ERK) e proteína cinase dependente de AMPc (PKA) respectivamente. O presente estudo avaliou como a expressão de PrP cem astrócitos pode modular a interação neurônioglia e o papel de STI1 como um fator autócrino em astrócitos. PrPc modula a interação neurônio-glia, a produção de fatores tróficos solúveis e a organização da laminina secretada na matriz extracelular pelos astrócitos. Desta forma, a expressão de PrP ctanto em astrócitos quanto em neurônios é essencial para a neuritogênese e sobrevivência neuronal. O papel autócrino de STI1 em astrócitos também foi demonstrado. A interação PrPc-STI1 previne a morte celular por ativação da via de PKA, e ativa a diferenciação astrocitária, de uma forma protoplasmática para uma fibrosa pela indução de ERK1/2. De acordo com estes resultados, um menor grau de diferenciação é encontrado em camundongos deficientes para PrPc...
The physiological functions of PrPc are under intense investigation and characterization, particularly those associated with brain development. In neurons, the association of PrPc with its ligand, STI1, induces neuritogenesis and neuroprotection via ERK and PKA signaling pathways, respectively. The present study evaluated whether PrPc expression in astrocytes modulates neuron-glia crosstalk and the autocrine role of STI1 in astrocytes. PrPc modulates neuron-glia interaction, the production and secretion of soluble factors, and the organization of the laminin in the extracellular matrix. PrPc expression in neurons and astrocytes is essential to neuritogenesis and neuronal survival. The autocrine role of STI1 in astrocytes was also demonstrated. The PrPc-STI1 interaction prevents cell death in a PKA-dependent manner, and induces astrocyte differentiation, from a flat to a process-bearing morphology in an ERK1/2 dependent manner. We showed that PrPccnull astrocytes presented a slower rate of astrocyte maturation than wild-type ones, with reduced expression of GFAP and increased vimentin and nestin expression...